Publikationen
Articles in Refereed Journals (International)
-
Kirsch, F. ; Schramm, A. ; Kurz, C. ; Schwarzkopf, L. ; Lutter, J. ; Szentes, B. ; Leidl, R.
(2020):
Effect of BMI on health care expenditures stratified by COPD Gold severity grades: Results from the LQ-DMP Study
erschienen in: Respiratory Medicine Nov 02
-
Kirsch, F. ; Becker, C. ; Kurz, C. ; Schramm, A.
(2020):
Effects of adherence to pharmacological secondary prevention after acute myocardial infarction on health care costs - an analysis of realworld
erschienen in: BMC Health Services Research 20.1 pp. 1-17. BioMed Central
-
Kirsch, F.; Becker, C. ; Schramm, A.; Maier, W. ; Leidl, R.
(2020):
Effects of continuous enrollment in a structured Disease Management Program in patients with coronary artery disease after acute myocardial infarction on adherence to guideline recommended medication, health care expenditures, and survival
erschienen in: European Journal of Health Economics, 1 Feb https://doi.org/10.1007/s10198-020-01158-z
-
Huber, MB; Kurz, C. ; Kirsch, F. ; Schwarzkopf, L.; Schramm, A. ; Leidl, R.
(2020):
The relationship between body mass index and health-related quality of life in COPD: real-world evidence based on claims and survey data
erschienen in: Respiratory Research 21:291
-
Szentes, BL.; Schwarzkopf, L.; Kirsch, F. ; Schramm, A. ; Leidl, R.
(2019):
Measuring quality of life in COPD patients: Comparing disease-specific supplements to the EQ-5D-5L
erschienen in: Expert Reviews of Parmacoeconomic Outcomes, Received 14 May 2019, Accepted 28 Aug 2019, Published online: 12 Sep 2019
-
Kirsch, F.
(2016):
Economic Evaluations of Multicomponent Disease Management Programs with Markov Models: A Systematic REview
erschienen in: Value Health. 2016 Dec;19(8):1039-1054.doi:10.1016/j.jval.2016.07.004. Epub 2016 Sep 16.
-
Kirsch, F.
(2015):
A systematic review of Markov models evaluating multicomponent disease management programs in diabetes
erschienen in: Expert review of pharmacoeconomics & outcomes research, 1-24
-
Kirsch, F.
(2015):
A systematic review of quality and cost–effectiveness derived from Markov models evaluating smoking cessation interventions in patients with chronic obstructive pulmonary disease
erschienen in: Expert Rev. Pharmacoecon. Outcomes Res. Early online, 1–16, doi: 10.1586/14737167.2015.1001976
nach oben
Articles in Refereed Journals (National)
-
Fischer, L.; Arnold, M.; Kirsch, F.; Leidl, R.
(2016):
Wirtschaftlichkeit des 21 Gene Tests in der Behandlung von Patientinnen mit noda-positivem Mammakarzinom
erschienen in: Das Gesundheitswesen. 78:772-780
-
Kirsch, F.; Teuner, CM.; Menn, P.; Leidl, R.
(2013):
Krankheitskosten für Asthma und COPD bei Erwachsenen in der Bundesrepublik Deutschland
erschienen in: Das Gesundheitswesen e-pub 3 April DOI:10.1055/s-0033-1333742
nach oben
Articles in Refereed Proceedings (International)
-
Szentes, B.; Schwarzkopf, L.; Kirsch, F. ; Huber, M. ; Schramm, A. ; Leidl, R.
(2019):
Different methods to classify COPD patients into the ABCD severity groups - Preliminary results of the LQ-DMP projekt
erschienen in: European Respiratory Journal 2019 54: PA2495; DOI: 10.1183/13993003.congress-2019.PA2495
-
Kirsch, F.
(2015):
A Systematic Review Of Markov Models Evaluation Multi-Component Disease Management Programs
erschienen in: Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research, 18(7), A502
-
Kirsch, F.
(2014):
A systematic review of cost-effectiveness and quality derived from models evaluation smoking cessation interventions in patients with COPD
erschienen in: European Respiratory Journal September 1, 2014 vol. 44 no. Suppl 58 202
-
Kirsch, F. ; Wenig, CM.; Menn, P.; Leidl, R.
(2012):
Variation of cost of chronic obstructive lung disease in adults in Germany: A systematic review.
erschienen in: Value in Health 15(7): A561.